Inhibiting CD36 palmitoylation reduces fatty acid overload and enhances the CD36–PGAM5–Fundc1 pathway to promote mitophagy, thereby improving cardiac function—a promising new direction for MI treatment (Zhang et al., 2025f). This evidence concerns the gene CD36 and myocardial infarction.